VA by @farahwehbe92.bsky.social
#NephSky #NephJC
www.nephjc.com/news/icraki-the-visual-abstract
VA by @farahwehbe92.bsky.social
#NephSky #NephJC
www.nephjc.com/news/icraki-the-visual-abstract
🫘 Intermittent HD or continuous RRT for critically ill patients with AKI?
⚖️ For years, trials suggested similar outcomes. Does the choice of modality affect survival?
💥 The ICRAKI trial challenges previous evidence
www.nejm.org/doi/10.1056/... #NephJC #TenPosts
🫘 Intermittent HD or continuous RRT for critically ill patients with AKI?
⚖️ For years, trials suggested similar outcomes. Does the choice of modality affect survival?
💥 The ICRAKI trial challenges previous evidence
www.nejm.org/doi/10.1056/... #NephJC #TenPosts
We saved metapod in a forest! 🎉
Did some minor rescues to get stronger. @t3finn.bsky.social is always excited to get out there and train. 😊
Unfortunately, got a meditite 10 lvls below that has almost equal stats to Finn (gotta benc you bud 😭)
Onto the Chasm! 🧗
We saved metapod in a forest! 🎉
Did some minor rescues to get stronger. @t3finn.bsky.social is always excited to get out there and train. 😊
Unfortunately, got a meditite 10 lvls below that has almost equal stats to Finn (gotta benc you bud 😭)
Onto the Chasm! 🧗
📋 ICRAKI: multicenter, open-label, noninferiority RCT across 38 French ICUs
🫘 Critically ill adults with severe AKI requiring RRT
⚖️ Intermittent HD vs continuous RRT as initial treatment
🎯 Primary outcome: MAKE90
📋 ICRAKI: multicenter, open-label, noninferiority RCT across 38 French ICUs
🫘 Critically ill adults with severe AKI requiring RRT
⚖️ Intermittent HD vs continuous RRT as initial treatment
🎯 Primary outcome: MAKE90
In your ICU, which RRT modality is most commonly used for hemodynamically unstable patients with AKI?
🔘 CRRT
🔘 SLED
🔘 IHD
💬 Does the ICRAKI trial make you reconsider your current practice?
In your ICU, which RRT modality is most commonly used for hemodynamically unstable patients with AKI?
🔘 CRRT
🔘 SLED
🔘 IHD
💬 Does the ICRAKI trial make you reconsider your current practice?
✍️ @rnflex.bsky.social @divyaveerssneph.bsky.social
www.nephjc.com/news/icraki1...
✍️ @rnflex.bsky.social @divyaveerssneph.bsky.social
www.nephjc.com/news/icraki1...
I need a charmander... who is with me?
(if you want to join the journey, just lmk 😊)
I need a charmander... who is with me?
(if you want to join the journey, just lmk 😊)
It did its job; it got me into Mystery Dungeon proper. But it would have been nice if the gameplay was more challenging or
It did its job; it got me into Mystery Dungeon proper. But it would have been nice if the gameplay was more challenging or
💡 Strengths: randomized, multicenter, contemporary trial with clear RRT indications
⚠️ Limitations: early termination, open-label design, treatment crossover and slightly subtarget IHD dose
🫘 Kidney-specific outcomes remain uncertain
💡 Strengths: randomized, multicenter, contemporary trial with clear RRT indications
⚠️ Limitations: early termination, open-label design, treatment crossover and slightly subtarget IHD dose
🫘 Kidney-specific outcomes remain uncertain
🫘 ICRAKI challenges the assumption of equivalent outcomes with IHD and CRRT in severe AKI
⚠️ Higher mortality with initial IHD, but early stopping warrants caution
💡 RRT choice remains individualized, guided by clinical context and resources
🫘 ICRAKI challenges the assumption of equivalent outcomes with IHD and CRRT in severe AKI
⚠️ Higher mortality with initial IHD, but early stopping warrants caution
💡 RRT choice remains individualized, guided by clinical context and resources
https://bakersfieldnow.com/news/nation-world/massie-says-he-will-reintroduce-impeachment-articles-against-hegseth-after-midterms-defense-secretary-congress-mike-johnson-hakeem-jeffries-president-trump-rrt
https://bakersfieldnow.com/news/nation-world/massie-says-he-will-reintroduce-impeachment-articles-against-hegseth-after-midterms-defense-secretary-congress-mike-johnson-hakeem-jeffries-president-trump-rrt
www.nephjc.com/news/icraki1...
www.nephjc.com/news/icraki1...
📖 Read the full ICRAKI trial:
Gaudry S et al. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury.
NEJM, 2026.
🔗 DOI: 10.1056/NEJMoa2608397
🫘 Check out the #NephJC discussion! @DivyaveerSSNeph @rn_flex
www.nephjc.com/news/icraki1...
📖 Read the full ICRAKI trial:
Gaudry S et al. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury.
NEJM, 2026.
🔗 DOI: 10.1056/NEJMoa2608397
🫘 Check out the #NephJC discussion! @DivyaveerSSNeph @rn_flex
www.nephjc.com/news/icraki1...
https://cbs4local.com/news/nation-world/massie-says-he-will-reintroduce-impeachment-articles-against-hegseth-after-midterms-defense-secretary-congress-mike-johnson-hakeem-jeffries-president-trump-rrt
https://cbs4local.com/news/nation-world/massie-says-he-will-reintroduce-impeachment-articles-against-hegseth-after-midterms-defense-secretary-congress-mike-johnson-hakeem-jeffries-president-trump-rrt
Reward-Guided RRT* for Budgeted Task and Motion Planning
https://arxiv.org/abs/2610.35289
Reward-Guided RRT* for Budgeted Task and Motion Planning
https://arxiv.org/abs/2610.35289
Estamos no #OutubroRosa, de prevenção ao #CâncerDeMama. Mas lembremo-nos: existe também o #Câncer de Mama Masculino!
Em: wp.me/p4RTuC-rRt
.
Estamos no #OutubroRosa, de prevenção ao #CâncerDeMama. Mas lembremo-nos: existe também o #Câncer de Mama Masculino!
Em: wp.me/p4RTuC-rRt
.